Stockreport

BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts [Yahoo! Finance]

BIOSTEM TECHNOLOGIES NEW  (BSEM) 
PDF the development, manufacture, and commercialization of placental-derived tissue allografts for advanced wound care, today announced that it has retained the services of [Read more]